BioAtla, Inc. (BCAB)
BioAtla, Inc. engages in the development of novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its CAB portfolio include MABs & ADCS, BA3011, and BA3021. The company was founded by Jay M. Short and Carolyn Anderson in March 2007 and is headquartered in San Diego, CA.
Address
11085 TORREYANA ROAD
SAN DIEGO, CA 92121
Founded
2007
Number of Employees
65
Website
http://www.BioAtla.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)